Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

GLIS2 MUTATION survey

Leucémie Myéloïde Aiguë (LMA)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Second allograft for pediatric AML

Études rétrospectives

Leucémie Myéloïde Aiguë (LMA)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

BUCHBINDER, Nimrod

Treo versus Bu-based Conditioning Regimens for First Allogeneic SCT in Children with AML in Complete Remission

Études rétrospectives

Leucémie Myéloïde Aiguë (LMA)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Hemalatha G Rangarajan

Impact of Different Conditioning Regimens Administered for SCT in Pediatric Chronic Myeloid Leukemia (CML) CML

Études rétrospectives

Leucémie Lymphoïde Chronique (LLC)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Meinolf Suttorp

Hematopoietic stem cell transplantation (HSCT) in patients with Down syndrome

Closed Survey/Study

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Greffe de cellules souches hématopoïétiques (HSCT) chez les patients atteints du syndrome de Down

Toutes les maladies

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Impact of SCT for Histiocytic Sarcoma (HS) in children

Études rétrospectives

Autres anomalies non malignes

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Giorgio Ottaviano (London)

Survey about Antiviral Management (DNA viruses) at Pediatric Transplant Centers – PDWP and IDWP, EBMT

Toutes les maladies

Paediatric Diseases Working Party (PDWP)

Infectious Diseases Working Party (IDWP)

Type de traitement

Investigateur principal

International report of allogeneic HSCT in PKD

Études rétrospectives

Autres anomalies non malignes

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Elodie Gouache (Paris)

Second malignancies after SCT for Hypodiploid ALL: TP53 mutation

Leucémie Aiguë Lymphoblastique (LAL)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Laura Bettini (Monza)

ALL study, patients transplanted between 2 and 4 years old

Études rétrospectives

Leucémie Aiguë Lymphoblastique (LAL)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Krzysztof Kalwak

Use of Letermovir after transplant in pediatric patients

Études rétrospectives

Toutes les maladies

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Giovanna Lucchini (London)